SCHEMBL8514369

SCHEMBL8514369

CCNc1nnc(-c2ccccc2O)o1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.53
▸ ALDH1A1 P00352 4/20 0.53
▸ HSD17B10 Q99714 3/20 0.53
▸ NPC1 O15118 3/20 0.53
▸ RAB9A P51151 3/20 0.53
▸ TP53 P04637 1/20 0.53
▸ HPGD P15428 3/20 0.47
▸ PKM P14618 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ POLB P06746 2/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ ALOX12 P18054 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ ALOX15 P16050 1/20 0.43
▸ RXFP1 Q9HBX9 1/20 0.42
▸ LMNA P02545 2/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9737555 0.77 NPC1 (0.64) KDM4EALDH1A1HSD17B10NPC1RAB9A
SCHEMBL27785893 0.75 KDM4E (0.55) KDM4EALDH1A1HSD17B10NPC1RAB9A
SCHEMBL10835670 0.73 RAB9A (0.55) KDM4EALDH1A1HSD17B10NPC1RAB9A
SCHEMBL7942754 0.71 KDM4E (0.58) KDM4EALDH1A1HSD17B10NPC1RAB9A
SCHEMBL10200978 0.71 KDM4E (0.48) KDM4EALDH1A1HSD17B10NPC1RAB9A
SCHEMBL6450028 0.69 RAB9A (0.69) KDM4EALDH1A1HSD17B10NPC1RAB9A
SCHEMBL2800972 0.69 ALDH1A1 (0.51) KDM4EALDH1A1HSD17B10NPC1RAB9A
SCHEMBL3826961 0.69 HPGD (0.61) KDM4EALDH1A1HSD17B10NPC1RAB9A
SCHEMBL13927483 0.69 HPGD (0.61) KDM4EALDH1A1HSD17B10NPC1RAB9A
SCHEMBL28529043 0.69 HPGD (0.61) KDM4EALDH1A1HSD17B10NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2841471-B1 ACTIVATOR COMPOSITIONS, THEIR PREPARATION, AND THEIR USE IN CATALYSTS GRACE W R & CO (US) 2020-05-06 — — EP disclosed
US-20190153135-A1 Activator Compositions, Their Preparation, And Their Use In Catalysts GRACE W R & CO (US) 2019-05-23 — — US disclosed
US-10221264-B2 Activator compositions, their preparation, and their use in catalysts W. R. GRACE & CO.-CONN. (US) 2019-03-05 — — US disclosed
CN-104854150-B Activator compositions, their preparation, and their use in catalysts 阿尔比马尔公司 2017-05-24 — — CN disclosed
CN-104854150-A Activator compositions, their preparation, and their use in catalysts ALBEMARLE CORP 2015-08-19 — — CN disclosed
US-20150105238-A1 ACTIVATOR COMPOSITIONS, THEIR PREPARATION, AND THEIR USE IN CATALYSTS W. R. GRACE & CO.-CONN. 2015-04-16 — — US disclosed
EP-2643366-B1 ACTIVATOR COMPOSITIONS, THEIR PREPARATION, AND THEIR USE IN CATALYSIS ALBEMARLE CORP (US) 2015-03-25 — — EP disclosed
EP-2841471-A1 ACTIVATOR COMPOSITIONS, THEIR PREPARATION, AND THEIR USE IN CATALYSTS Albemarle Corporation (US) 2015-03-04 — — EP disclosed
US-8895465-B2 Activator compositions, their preparation, and their use in catalysis ALBEMARLE CORPORATION (US) 2014-11-25 — — US disclosed
WO-2013162745-A1 ACTIVATOR COMPOSITIONS, THEIR PREPARATION, AND THEIR USE IN CATALYSTS ALBEMARLE CORPORATION (US) 2013-10-31 — — WO disclosed
EP-2643366-A2 ACTIVATOR COMPOSITIONS, THEIR PREPARATION, AND THEIR USE IN CATALYSIS Albemarle Corporation (US) 2013-10-02 — — EP disclosed
US-20130253155-A1 Activator Compositions, Their Preparation, and Their Use In Catalysis ALBEMARIE CORPORATION (US) 2013-09-26 — — US disclosed
WO-2012071205-A2 ACTIVATOR COMPOSITIONS, THEIR PREPARATION, AND THEIR USE IN CATALYSIS ALBEMARLE CORPORATION (US) 2012-05-31 — — WO disclosed
Send feedback